Search Ontology:
ChEBI

19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha

Term ID
CHEBI:73951
Synonyms
  • (13E,15S)-9alpha,11alpha,15,19-tetrahydroxy-2,3-dinor-6-oxoprost-13-en-1-oic acid
  • 19-hydroxy-2,3-dinor-6-keto-prostaglandin F1alpha
  • 19-hydroxy-2,3-dinor-6-oxo-PGF1alpha
  • 19-hydroxy-2,3-dinor-6-oxo-prostaglandin F1alpha
  • 19-hydroxy-6-keto-2,3-dinor-prostaglandin F1alpha
  • 2,3-dinor-6-keto-19-hydroxy-prostaglandin F1alpha
  • 2,3-dinor-6-oxo-19-hydroxy-prostaglandin F1alpha
  • 5-{(1R,2R,3R,5S)-2-[(1E,3S)-3,7-dihydroxyoct-1-en-1-yl]-3,5-dihydroxycyclopentyl}-4-oxopentanoic acid
(all 8)
Definition
A prostanoid that is 2,3-dinor-6-oxo-prostaglandin F1alpha in which a hydrogen at position 19 is replaced by a hydroxy group.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
Phenotype where environments contain 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
Phenotype modified by environments containing 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
Phenotype affecting 19-hydroxy-2,3-dinor-6-oxoprostaglandin F1alpha
Human Disease Model
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.